Form 10-Q · Quarterly report
Dover Corporation 10-Q, filed Jul 23, 2026
- Filed
- CIK
- 0000029905
- Accession no.
- 0000029905-26-000027
Summary
Dover Corporation reported second-quarter 2026 revenue of $2.2 billion, up 6.9% year over year, with organic revenue growth of 4.8% and bookings up 16.1% to $2.3 billion. Net earnings were $312.2 million, and diluted earnings per share from continuing operations were $2.31.
Key points
- Dover's Q2 2026 revenue rose 6.9% to $2.2 billion, driven by 4.8% organic growth, 1.2% acquisition-related growth, and 0.9% favorable foreign currency translation.
- Bookings were $2.3 billion, up 16.1% year over year, with increases across all segments.
- Restructuring and other costs were $24.6 million, including $17.0 million of restructuring charges primarily from headcount reductions and exit costs in Climate & Sustainability Technologies and Engineered Products.
- The company completed a $500 million accelerated share repurchase program, repurchasing 2,487,662 shares at a volume-weighted average price of $200.99, less a discount.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion OVERVIEW Dover is a diversified global manufacturer and solutions provider delivering innovative equipment and components, consumable supplies, aftermarket parts, software and digital solutions, and support services through five operating segments: Engineered Products, Clean Energy & Fueling, Imaging & Identification, Pumps & Process Solutions, and Climate & Sustainability Technologies. The Company's entrepreneurial business model encourages, promotes and fosters deep customer engagement and collaboration, which has led to Dover's well-established and valued reputation for providing superior customer service and industry-leading product innovation. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.